All Stories

  1. Correlation between flow cytometry and molecular findings in autosomal recessive chronic granulomatous disease: A cohort study from Oman
  2. Targeted next generation sequencing identifies a novel β-spectrin gene mutation A2059P in two Omani children with hereditary pyropoikilocytosis
  3. Chediak-Higashi Syndrome
  4. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies
  5. Thiamine responsive megaloblastic anemia: The puzzling phenotype
  6. Potential pitfalls in the diagnosis of Hb Handsworth in areas with high prevalence of HbS
  7. First reported case of compound heterozygosity for HbA2-Yialousa (HBD: c.82 G>C) and HbA2-Wrens (HBD: c.295 G>A) in Oman
  8. Hematopoietic Stem Cell Transplantation for Sickle Cell Anemia with Busulfan-Based Reduced Intensity Conditioning: Cure and Fertility
  9. Idiopathic thrombocytopenic purpura and hypokalaemic dRTA with compensated haemolysis and striking acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygote
  10. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients
  11. Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population
  12. dRTA and hemolytic anemia: first detailed description of SLC4A1 A858D mutation in homozygous state
  13. Combined effect of <i>CYP2C9</i> and <i>VKORC1</i> polymorphisms on warfarin maintenance dose in Omani patients
  14. The β-globin promoter −71 C>T mutation is a β+ thalassemic allele
  15. Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study
  16. Hb Sheffield [β58(E2)Pro→His] in Oman: Potential Pitfall in Genetic Counseling
  17. Hb A2′ (Hb B2) in the Omani Population and Diagnostic Significance
  18. Long Term Outcomes of Allogeneic Transplant Using Non-Radiation Based Preparative Regimens for Acute Lymphoblastic Leukemia
  19. Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
  20. A Novel Deletional β-Thalassemic Variant in an Ethnic Qatari Patient
  21. T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman
  22. Hematopoietic stem cell transplantation in Oman